Last reviewed · How we verify
NCT04570007
Vitreous Fragments Length After Pars Plana Vitrectomy
trial testing Pars Plana Vitrectomy in Vitreous Disorder in 25 participants. Status unknown.
30 October 2021
Quick facts
| Lead sponsor | Ospedale Policlinico San Martino |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 25 |
| Start date | 20 September 2020 |
| Primary completion | 30 October 2021 |
| Estimated completion | 10 December 2021 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- Pars Plana Vitrectomy
Conditions studied
- Vitreous Disorder — all drugs for Vitreous Disorder →
- Vitreous Anomalies — all drugs for Vitreous Anomalies →
Sponsor
Ospedale Policlinico San Martino
Who can join
Adults 18 to 90, any sex, with Vitreous Disorder or Vitreous Anomalies. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To measure vitreous collagen fragments length after pars plana vitrectomy performed at different cut rates
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04570007
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Pars Plana Vitrectomy
Trials testing the same drug.
- NCT04192994 — Evaluation do Early Pars Plana Vitrectomy in Acute Endophthalmitis · NA · completed
- NCT04089033 — Retinal Displacement After Pneumatic Versus Vitrectomy for Retinal Detachment (ALIGN) · completed
- NCT06559488 — IVB for Post-vitrectomy Hemorrhage in Diabetic Eyes · NA · completed
- NCT04139811 — Evaluation of Visual Functions After Pars Plana Vitrectomy With and Without Internal Limiting Membrane Peeling in RRD · NA · completed
Other recruiting trials for Vitreous Disorder
Currently open trials in the same condition.
- NCT06520410 — Safety and Efficacy of 18 mm Short Vitrectomy Probe for Pediatric Vitreoretinal Surgeries · Phase 4 · recruiting
Other Ospedale Policlinico San Martino trials
Trials by the same sponsor.
- NCT07029620 — Peripheral Neuropathy Rehabilitation With Stabilometric Platforms (NEUROSTAB) · NA · not yet recruiting
- NCT07235111 — Omics Sciences for the Identification of Pathogenetic Mechanisms and Biomarkers in Neurodegenerative Diseases · recruiting
- NCT06809673 — PA.RI.GE. Study. The Prognostic Role of Inflammatory Circulating Biomarkers in HNSCC: a Prospective Multicentric Trial · enrolling by invitation
- NCT06274580 — Endovascular vs Conservative Treatment in Patients With Chronic Subdural Hematomas and Mild Symptoms · NA · unknown
- NCT07061093 — Prospective Evaluation on the Role Exerted by Hormonal Contraceptives on 24-h Blood Pressure. A Prospective Observationa · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04570007 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ospedale Policlinico San Martino
- Last refreshed: 27 October 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04570007.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing